My research focuses on understanding the cytokine and metabolic regulation of regulatory T cells residing in non-lymphoid tissues such as the visceral adipose tissue and skin. I started my lab at Emory University in 2020, right at the beginning of the COVID pandemic. It was difficult but I received a [READ MORE]
Clinical Trials of interest to cytokine & interferon researchers Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not? (BIOSTOP) ClinicalTrials.gov ID NCT03011268 Sponsor Helse Møre og Romsdal HF Information provided by Helse Møre og Romsdal HF (Responsible Party) Last Update Posted 2023-03-17 Evaluation of [READ MORE]
18:00 – 21:00, October 21 (Mon), 2024 at the Spaceshare Samseong COEX Center (close to the meeting venue) Primary Goal: Enhance the Early Career Researchers (ECR) meeting experience by facilitating networking opportunities at the outset, fostering relationships that extend beyond the meeting. Foster interactions between KAI members and Global Members. [READ MORE]
Viral modulation of type II interferon increases T cell adhesion and virus spread Herpes and poxviruses express viroceptors, viral proteins that bind cytokines and modulate their activity. Until now, all known viroceptors that bind interferon (IFN) have been discovered exclusively in poxviruses and inhibit IFN activity through blocking the cytokine-receptor [READ MORE]
We have recently become aware of scammers targeting conference attendees. DO NOT provide any personal information or make any payments in response to unsolicited emails. (See examples) Cytokines 2024 | KAI 2024 and our conference hotels will never send emails or place phone calls to individuals to promote specific accommodations. [READ MORE]
Clinical Trials of interest to cytokine & interferon researchers huCART19-IL18 in NHL/CLL Patients ClinicalTrials.gov ID NCT04684563 Sponsor University of Pennsylvania Information provided by University of Pennsylvania (Responsible Party) Last Update Posted 2024-05-13 Low Dose IL-2 for the Treatment of Crohn’s Disease ClinicalTrials.gov ID NCT04263831 Sponsor Boston Children’s Hospital Information provided [READ MORE]
British playwright Tom Stoppard got it right when he said, “It’s not the voting that’s democracy; it’s the counting.” Some of you may recall a few questions about the final results of last year’s “Cytokine Bracket.” The 2024 edition of the King of Pathogens Memorial Cytokine Bracket has resolved those issues. Scan the QR code to vote.
And while you’re at it, if you are an ICIS member take a moment to vote in the ICIS leadership elections. Also on the ballot is a proposal to amend the number and responsibilities of some Standing Committees listed in the Bylaws.
Ballots were emailed to all members on July 1 with a reminder on July 10th, directly from ElectionBuddy.com. If you didn’t receive yours, please contact the ICIS office. [READ MORE]
My main research interest now is the convergence between immunology and regenerative biology, and thus, the Franklin Lab is focused on understanding the way immune cells contribute to tissue remodeling and repair. The ICIS community has been so warm and welcoming! Being a member of ICIS has given me a [READ MORE]
Each year Members of ICIS are asked to elect members of the governing council and nominations committee. This year, members are also asked to vote on a change to the Bylaws of the Society regarding Standing Committees. These important elections determine the direction and the future of the Society. All [READ MORE]
Congratulations!The 2024 ICIS-Pfizer Trainee Award Winners are: Abstract Number Presenting Author Affiliation Country A-0030 Amir Shamshirian QIMR Berghofer Medical Research Institute Australia A-0070 In Hwa Jang University of Minnesota United States A-0084 Benjamin Broomfield The Walter and Eliza Hall Institute (WEHI) Australia A-0450 Eugenio Contreras Castillo National Autonomous University of [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
